📰 Resources Report News
Page 2 - Resources Report News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Resources Report. Real-time updates on events, politics, business and more.
March 24, 2023
Religious organizations are an often-overlooked champion in bringing about more equitable, sustainable cities, engaging in everything from climate resilience to affordable housing.
March 16, 2023
/CNW/ - CanAsia Energy Corp. ("CanAsia" or the "Company") (TSXV: CEC) reports 2022 year-end and fourth quarter consolidated financial and operating results....
March 13, 2023
Alvopetro Energy Ltd. (TSX-V: ALV; OTCQX: ALVOF) today announced that Corey C. Ruttan, President and Chief Executive Officer, will present live at the Oil & Gas
January 3, 2023
In the Indian state of Odisha, COVID-19 threatened an unemployment and poverty crisis. The state's Urban Wage Employment Initiative averted disaster by providing public works jobs to the urban poor.
October 15, 2022
Also: What is your Republican Party present day?
October 9, 2022
The UK oil and gas licensing round announced October 6 by the North Sea Transition Authority, will boost British gas supplies, sustain the UK’s energy industry and strengthen plans for a low-carbon future, said Offshore Energies UK (OEUK).
September 8, 2022
– Cabozantinib in combination with nivolumab and ipilimumab significantly reduced the risk of disease progression or death compared with the combination of nivolumab and ipilimumab –– Median progression-free survival was not yet reached with the combination of cabozantinib, nivolumab and ipilimumab versus 11.3 month...
September 7, 2022
08.09.2022 - Exelixis, Inc. (Nasdaq: EXEL) today announced detailed results from COSMIC-313, an ongoing phase 3 pivotal trial evaluating the combination of cabozantinib (CABOMETYX), nivolumab and ipilimumab versus the combination of nivolumab and ipilimumab in ...
September 7, 2022
- Cabozantinib in combination with nivolumab and ipilimumab significantly reduced the risk of disease progression or death compared with the combination of nivolumab and ipilimumab - - Median progression-free
August 10, 2022
/CNW/ - Pan Orient Energy Corp. ("Pan Orient" or the "Company") (TSXV: POE) reports 2022 second quarter consolidated financial and operating results. Please...